Interview with Stacey Hunt, Breast Cancer Survivor Who Found Cancer After a Clear Mammogram

Table of Contents

• When a “normal” mammogram is not the whole story
• Why dense breasts can change what screening should look like
• The type of breast cancer that hides
• The phone call nobody ever forgets
• Choosing treatment after early detection
• Menopause after breast cancer
• The emotional reality of survivorship
• The message every woman needs to hear
• FAQ
• A final word on self advocacy

When a “normal” mammogram is not the whole story

Some stories stay with us because they expose a gap in women’s healthcare that is far too common. We can do everything right, keep up with screening, have no symptoms, and still be told we are fine when we are not. That is exactly why this conversation matters.

In this interview, Dr. Thais Aliabadi and Mary Alice Haney talk through how a clear mammogram did not mean clear results for Stacey Hunt. She learned her lifetime breast cancer risk was high, pushed for an MRI, and found a tiny invasive lobular breast cancer that standard imaging had missed. Her story is deeply personal, but it is also practical. It gives us a roadmap for what to ask, what to know, and how to advocate for ourselves when something does not add up.

How did this all begin for us?

It started with a story that felt both intimate and universal. Stacey had been listening to a conversation about breast cancer risk, dense breast tissue, and the importance of more complete screening for women who are at higher risk. What struck her most was the idea that someone can have no symptoms and still have an aggressive cancer developing quietly.

That landed hard. A lot of us assume cancer announces itself. We think there will be pain, a lump, a warning sign. But sometimes there is none of that. Sometimes the only clue is hidden in risk assessment, family history, breast density, or testing that was never offered in the first place.

After hearing that, Stacey went home and completed a lifetime breast cancer risk assessment. It was simple, quick, and eye opening. She then asked her doctor to order hereditary cancer testing through MyRisk. That decision changed everything.

What is a lifetime breast cancer risk assessment, and why do we keep talking about it?

This is one of the most important takeaways from the entire conversation. Every woman should know her lifetime risk of breast cancer. Not vaguely. Not someday. Actually know the number.

A lifetime risk assessment pulls together the pieces that shape our odds over time. That can include:

• Family history of breast cancer
• Family history of ovarian, pancreatic, or prostate cancer
• Personal history such as prior breast biopsies
• Breast density
• Height and weight
• Other risk factors that are easy to answer in a short questionnaire

For many women, this is not being done routinely, which is a major problem. A normal mammogram is only one piece of the picture. Risk tells us how aggressive we need to be with screening. If we never calculate it, we may never know we qualify for additional imaging.

That is why conversations like this guide to advocating for yourself at the doctor matter so much. Women are often dismissed, delayed, or told not to worry when they should be getting answers.

What did Stacey’s results show?

Her hereditary cancer panel did not reveal one of the major known cancer causing mutations. That might sound reassuring at first, but the story did not end there.

Her overall risk score came back at 28 percent. In breast cancer screening, anything over 20 percent is considered high risk. That put her in a category where MRI screening should be part of the plan.

That result shocked her. She had no symptoms. She had recently had a mammogram that was read as negative. And still, her true risk profile said she needed more.

This is an important distinction. Genetic testing is not only about whether we carry a well known mutation like BRCA. Some tests also combine personal history with small genetic markers that, together, can raise risk significantly. One marker alone may mean very little. Many of them together can shift the picture in a big way.

What factors pushed her into the high risk category?

Several things contributed. She had a family history of breast cancer in a second degree relative. She also had extremely dense breasts. That matters more than many women realize.

Dense breast tissue does two things. First, it can increase breast cancer risk. Second, it can make cancer harder to see on a mammogram. That is a dangerous combination.

About half of women have dense breasts. Yet many do not know whether their breasts are dense because they never read the report from their mammogram, or no one explains it to them. That report matters. If it says the breasts are heterogeneously dense or extremely dense, that should change the conversation about screening.

For more on how breast imaging can reveal broader health risks, we also recommend this article on what mammograms can reveal beyond breast cancer. It is another reminder that reports deserve to be read carefully, not filed away unread.

Why dense breasts can change what screening should look like

What imaging should we ask for if we have dense breasts?

If we have dense breast tissue, the first step is making sure we are not relying on outdated or incomplete imaging.

The recommendation explained in this conversation was clear:

• Ask for a 3D mammogram, not a 2D mammogram
• If breasts are dense, ask for a breast ultrasound in addition to mammography
• If lifetime breast cancer risk is 20 percent or higher, ask for a breast MRI too

A 3D mammogram gives a much more detailed look through breast tissue, almost like viewing the breast in thin layers rather than a flatter image. For dense breasts, that can make a huge difference.

Ultrasound adds another level of detection, especially when mammography alone may miss something hidden in dense tissue.

And MRI becomes critical when risk is high. It is not used casually. It is used because for high risk women, the benefit of seeing what mammogram may miss can be lifesaving.

What happened when Stacey asked for the MRI?

This is the part that will feel familiar to a lot of women. She went to her doctor and requested the MRI because her risk score qualified her for it. Instead of support, she was brushed off.

She had a mammogram three months earlier. It had been read as negative. So she was told she was fine, that she was being dramatic, and that repeating mammography later would be enough.

That kind of response chips away at confidence. Even when we know something is worth pursuing, a dismissive doctor can make us doubt ourselves. That is why repeated education matters. Hearing the same information more than once gave Stacey the confidence to go back and insist on the MRI anyway.

That second push is what changed the outcome.

What did the MRI find?

The MRI revealed a very small lesion in her right breast, tucked deep under dense tissue. It measured only 0.6 centimeters. The earlier mammogram had not detected it.

A guided biopsy confirmed the diagnosis: invasive lobular carcinoma.

That detail matters because lobular breast cancer behaves differently than the more common ductal type. It can be harder to detect on standard imaging, especially in women with dense breasts. It does not always present in a neat, obvious way. It can be subtle, diffuse, and easy to miss.

In other words, this was exactly the kind of cancer that could have stayed hidden if she had not insisted on additional screening.

The type of breast cancer that hides

How is lobular breast cancer different from ductal breast cancer?

Ductal breast cancer starts in the milk ducts and is the most common form. It is also more likely to be picked up on routine mammography, sometimes even at a very early stage.

Lobular breast cancer starts in the milk producing glands, called lobules. It can be much more difficult to find, particularly in dense breast tissue. It does not always form a distinct lump that stands out clearly on imaging. That is part of why it can slip through the cracks.

Some lobular cancers can also involve both breasts, which is one reason women diagnosed with this type may think carefully about broader surgical options. The right choice is individual, but understanding the biology matters.

One of the most sobering points in the conversation was that even when imaging is done, lobular cancers can still be missed. MRI is valuable, but it is not perfect. That is exactly why women should not assume one normal test means all is well forever.

Why did early detection matter so much in this case?

Because catching cancer at stage 1 and catching it at stage 4 are two entirely different realities.

When breast cancer is found very early, treatment options are broader and outcomes are usually much better. Once disease is advanced, survival drops and treatment becomes more intense, more complicated, and more emotionally draining.

That is especially important with lobular cancer, where standard imaging may underperform and some tumors respond differently to chemotherapy compared with ductal cancers. The best strategy is to find it before it has had time to spread.

Stacey’s cancer was found early enough that her doctor could reassure her it was small and unlikely to be fatal. That reassurance came only because the MRI happened when it did.

The phone call nobody ever forgets

What does it feel like to hear you have cancer?

There is no clean or elegant way to describe it. Even when the tumor is small and the prognosis is good, the words hit like a collapse.

Stacey talked about the shock of getting the call alone, then telling her husband, then trying to process what came next. The immediate thoughts were the ones so many women have. What happens now? What treatment do I need? Am I going to survive this? How do I protect my family while I figure this out?

That moment can be profoundly isolating. Even when we are surrounded by people who love us, cancer still feels personal in a way that is hard to explain. It is our body, our fear, our mind racing ahead to all the worst places.

There was also a very human detail in this conversation that deserves to be said out loud. Mothers often hold a lot of this inside in the beginning. We try to get a plan before we tell our children. We shield them while we are still reeling ourselves. That can make an already devastating experience feel even lonelier.

What did her doctor say after the biopsy?

He called and admitted what mattered most. She had been right to push for the MRI.

That is validating, of course, but it is also frustrating. It should not take a cancer diagnosis for a woman’s concern to be taken seriously. If the risk score met the threshold, that should have been enough.

This is part of a bigger pattern in women’s healthcare. We see it with breast cancer, but also with endometriosis, PCOS, fertility struggles, menopause, chronic pain, and heart disease. Women are often told symptoms are stress, age, anxiety, or overreaction until the situation becomes undeniable. That wider problem is explored well in this piece on bias in women’s healthcare.

Choosing treatment after early detection

What treatment options were on the table?

Because the tumor was very small, her doctors strongly recommended lumpectomy followed by radiation. For many women with early stage disease, that is an appropriate and effective path.

But treatment is not just about removing a tumor. It is also about what allows us to live with the least fear and the most peace afterward. Stacey knew she had dense tissue in both breasts. She knew how easily this cancer had hidden. And she knew she did not want to spend the coming years cycling through constant scans and persistent anxiety if she had another option.

So she chose bilateral mastectomy.

Why would someone choose a double mastectomy if the cancer is tiny?

Because medical decisions are not made on pathology alone. They are made at the intersection of biology, psychology, risk tolerance, and lived experience.

In her case, several factors made that choice feel right:

• The cancer was lobular, which can be harder to detect
• Her breasts were extremely dense
• She wanted to reduce future anxiety and surveillance burden
• She wanted the most definitive risk reducing option that felt available to her

Another woman with the same diagnosis might choose differently. That is important to say. There is no universal right answer. There is only the right answer for the individual patient after informed discussion.

What kind of reconstruction did she choose?

She did not choose a standard implant based reconstruction. After a lot of research, she found a surgeon in New Orleans who specialized in advanced flap reconstruction. Specifically, she chose SGAP flap surgery, which uses tissue from the upper buttock to reconstruct the breasts.

This type of surgery reconnects blood vessels microsurgically and creates a breast using the patient’s own tissue rather than an implant. One reason it appealed to her was that it did not involve removing gluteal muscle, which helped preserve function and improve recovery.

She described the results as natural feeling and was back to exercise, including tennis, in less than three months.

That said, this kind of reconstruction is highly specialized, not widely available everywhere, and can be financially or geographically difficult to access. That is a reality many women face. Expertise in breast cancer reconstruction is not the same as expertise in cosmetic breast surgery, and choosing the right surgeon matters enormously.

What should we look for in a reconstructive surgeon?

The advice was simple and important. If we are considering reconstruction after mastectomy, we should look for a surgeon who regularly performs breast cancer reconstruction, not someone whose practice is mostly cosmetic augmentation.

Those are different skill sets. Rebuilding a breast after breast tissue has been removed is not the same thing as placing implants in otherwise intact breast anatomy.

We should ask questions such as:

• How often do you perform reconstruction after mastectomy?
• What reconstruction methods do you offer?
• What outcomes do your patients typically have?
• Can I speak with your team about flap versus implant options?
• What is the expected recovery, function, and appearance over time?

Menopause after breast cancer

Can women take hormone replacement after breast cancer?

This is one of the most asked questions in women’s health, and the answer is nuanced.

The standard approach today is still to avoid systemic hormone replacement after a breast cancer diagnosis, even in many cases where the cancer was not strongly hormone driven. There are studies suggesting increased recurrence risk in women who use hormones after treatment, and most oncologists remain very cautious.

That said, not all breast cancers are the same. Important factors include:

• Whether the tumor had estrogen or progesterone receptors
• How many years the patient has been cancer free
• The original stage of the cancer
• Whether breast tissue remains after surgery
• How severe menopause symptoms are
• Whether non hormonal treatments have already failed

There may be a very small subset of women, such as those with early stage triple negative disease, significant time since diagnosis, bilateral mastectomy, and severe uncontrolled symptoms, who could have an individualized discussion. But that is not the same thing as broad approval. For most women, the default answer remains no.

If systemic hormones are off the table, what can help?

This part of the conversation was practical and hopeful. When hormones are not an option, we do not just suffer through symptoms. We treat the symptoms directly.

Options discussed included:

• For vaginal dryness and painful sex: local vaginal estrogen, vaginal inserts, moisturizers, lubricants, vitamin E inserts
• For hot flashes: certain SSRIs, low dose paroxetine formulations, clonidine, gabapentin, magnesium
• For sleep: magnesium glycinate, magnesium L-threonate, gabapentin, trazodone
• For hair loss: oral minoxidil
• For skin: tretinoin, vitamin C, sunscreen, laser treatments where appropriate
• For brain fog: omega 3s and attention to sleep and exercise
• For metabolic changes and weight gain: exercise, lifestyle shifts, and in some cases medications like metformin or GLP 1 therapies

The broader message was that survivorship care has to be comprehensive. Women should not be told to just be grateful they are alive and endure everything else in silence. Quality of life matters.

The emotional reality of survivorship

Does breast cancer ever really leave you?

Not completely. That was one of the most honest parts of the discussion.

Even after treatment, the memory stays close. There are daily reminders. There is the way showering, getting dressed, or even routine follow up can bring the experience right back to the surface. There is also the lingering knowledge that recurrence is part of the language of survivorship, even when everything currently looks good.

That is why one woman’s “small early stage cancer” is never emotionally small to the woman living through it. The diagnosis changes how we think about time, family, health, and risk.

Can something this hard still change life for the better?

Strangely, yes. Not because cancer is a gift in any simple sense, but because major illness can strip life down to what matters most.

Stacey described the way it sharpened everything. Family, purpose, gratitude, priorities. It forced a clearer view of what deserves energy and what does not. That perspective shift is common among survivors, even while the grief and fear remain real.

There was another layer too. Her story has ripple effects. One woman pushing for her MRI can become the reason another woman asks about dense breasts, lifetime risk, or hereditary testing. That is how change spreads.

The message every woman needs to hear

If we remember only a few things, what should they be?

There were several points repeated again and again because repetition is often what helps truth stick. These are the big ones:

1. Know your lifetime risk of breast cancer. Do not assume average risk if nobody has calculated it.
2. Read your mammogram report. Find out whether your breasts are dense.
3. If you have dense breasts, ask for the right imaging. That usually means 3D mammography and ultrasound.
4. If your lifetime risk is 20 percent or higher, ask whether you need an MRI.
5. If you have family history of related cancers, ask about hereditary cancer testing.
6. If a doctor brushes you off and your concern is legitimate, push back or get another opinion.

There are not many cancers where we can do this much risk stratification ourselves. Breast cancer is one of them. That means we should use the tools we have.

Why are so few women being told this?

That is the question underneath everything. At a seminar with hundreds of women, only a tiny number knew their lifetime breast cancer risk. Stacey’s own doctor had not been routinely using this approach before her case.

This is not a knowledge problem on the patient side alone. It is a systems problem. Risk assessment is not being standardized well enough. Dense breast education is inconsistent. Follow through on supplemental imaging varies too much. And too many women are expected to connect the dots themselves.

Until that changes, self advocacy is not optional. It is part of care.

FAQs

Can you have breast cancer even if your mammogram is clear?

Yes. A clear mammogram does not rule out every cancer, especially in women with dense breasts. In Stacey’s case, the mammogram was negative, but an MRI later found a small invasive lobular cancer hidden deep in dense tissue.

What is considered high lifetime risk for breast cancer?

A lifetime breast cancer risk of 20 percent or higher is generally considered high risk. That threshold can qualify a woman for additional screening such as breast MRI.

Why do dense breasts matter so much?

Dense breasts matter because they can both increase breast cancer risk and make cancers harder to detect on mammography. If a report says breasts are heterogeneously dense or extremely dense, it is worth discussing supplemental imaging with a doctor.

What screening may be recommended for women with dense breasts?

The discussion emphasized 3D mammography instead of 2D mammography, plus breast ultrasound for dense breasts. If lifetime risk is 20 percent or higher, breast MRI may also be indicated.

What is invasive lobular breast cancer?

It is a type of breast cancer that starts in the milk producing glands rather than the ducts. It can be harder to detect on standard imaging and may be especially tricky to identify in women with dense breasts.

If hereditary cancer testing is negative, can risk still be high?

Yes. A woman can test negative for major inherited cancer mutations and still have a high lifetime risk based on personal history, family history, breast density, and smaller genetic markers that together raise risk.

Can women use hormone replacement therapy after breast cancer?

The standard approach is usually to avoid systemic hormone replacement after breast cancer. In rare and very specific cases, some doctors may discuss it individually, but most women are guided toward non hormonal symptom treatment instead.

What should we do if a doctor dismisses our concerns?

If the concern is backed by risk factors, symptoms, or accepted screening thresholds, it is reasonable to push back, ask direct questions, request the appropriate order, or seek a second opinion. Stacey’s story is a powerful example of why that matters.

A final word on self advocacy

The most powerful part of this interview is not only that a tiny cancer was found. It is that it was found because a woman trusted information, listened to her instincts, and refused to let one negative mammogram close the case.

We should not have to fight this hard to get appropriate care. But while the system catches up, we need to know the questions to ask. Know your lifetime risk. Know your breast density. Know when you qualify for more testing. And if someone makes you feel dramatic for asking, ask again anyway.

That is not overreacting. That is taking your health seriously.

This article was created from the video My Mammogram Was Clear. I Still Had Breast Cancer ft. Stacey Hunt | SHE MD for Dr. Thais Aliabadi’s website.